Humacyte (HUMA) Short Interest Ratio & Short Volume $2.34 -0.15 (-6.02%) Closing price 04:00 PM EasternExtended Trading$2.30 -0.04 (-1.71%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Humacyte Short Interest DataHumacyte (HUMA) has a short interest of 25.15 million shares, representing 20.00% of the float (the number of shares available for trading by the public). This marks a -3.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.9, indicating that it would take 6.9 days of the average trading volume of 3.75 million shares to cover all short positions.Current Short Interest25,150,000 sharesPrevious Short Interest26,090,000 sharesChange Vs. Previous Month-3.60%Dollar Volume Sold Short$36.47 millionShort Interest Ratio6.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares155,119,000 sharesFloat Size125,750,000 sharesShort Percent of Float20.00%Today's Trading Volume5,187,304 sharesAverage Trading Volume3,751,345 sharesToday's Volume Vs. Average138% Short Selling Humacyte? Sign up to receive the latest short interest report for Humacyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHUMA Short Interest Over TimeHUMA Days to Cover Over TimeHUMA Percentage of Float Shorted Over Time Humacyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202525,150,000 shares $36.47 million -3.6%20.0%6.9 $1.45 4/15/202526,090,000 shares $40.18 million -3.9%20.8%7.5 $1.54 3/31/202527,140,000 shares $46.27 million +2.0%21.6%7.9 $1.71 3/15/202526,600,000 shares $80.86 million +4.4%25.5%6.8 $3.04 2/28/202525,480,000 shares $86.63 million +5.8%24.4%6.4 $3.40 2/15/202524,080,000 shares $94.15 million +0.2%23.1%6 $3.91 1/31/202524,040,000 shares $110.10 million -6.2%23.0%5.6 $4.58 1/15/202525,640,000 shares $117.43 million -13.4%24.6%5.7 $4.58 12/31/202429,620,000 shares $149.58 million +34.9%28.4%6.3 $5.05 12/15/202421,960,000 shares $90.04 million +8.0%21.0%5 $4.10 Get the Latest News and Ratings for HUMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter. 11/30/202420,330,000 shares $91.89 million +6.2%19.6%6.7 $4.52 11/15/202419,140,000 shares $92.54 million +11.0%18.5%6.3 $4.84 10/31/202417,250,000 shares $87.11 million +3.4%17.6%5.8 $5.05 10/15/202416,680,000 shares $95.08 million +4.1%17.0%5.5 $5.70 9/30/202416,030,000 shares $87.20 million +14.4%16.4%5.1 $5.44 9/15/202414,010,000 shares $79.02 million +24.3%15.0%4.3 $5.64 8/31/202411,270,000 shares $68.18 million -1.2%12.1%3.4 $6.05 8/15/202411,410,000 shares $70.06 million -5.0%12.4%3.3 $6.14 7/31/202412,010,000 shares $113.61 million -17.7%13.1%3.5 $9.46 7/15/202414,600,000 shares $122.64 million +77.0%15.9%4.8 $8.40 6/30/20248,250,000 shares $39.60 million +58.7%9.0%3 $4.80 6/15/20245,200,000 shares $36.66 million +5.9%5.7%2.2 $7.05 5/31/20244,910,000 shares $36.73 million +17.2%5.4%2.4 $7.48 5/15/20244,190,000 shares $27.11 million -6.7%4.6%2.4 $6.47 4/30/20244,490,000 shares $17.60 million +14.0%5.0%3.2 $3.92 4/15/20243,940,000 shares $11.31 million -1.0%4.4%3 $2.87 3/31/20243,980,000 shares $12.38 million +5.3%4.6%4.1 $3.11 3/15/20243,780,000 shares $12.25 million -36.5%4.5%4.3 $3.24 2/29/20245,950,000 shares $25.88 million -9.3%7.0%7.6 $4.35 2/15/20246,560,000 shares $29.26 million +7.0%8.8%12 $4.46 1/31/20246,130,000 shares $20.35 million No Change8.2%13 $3.32 1/15/20246,130,000 shares $16.24 million +1.7%8.2%13.7 $2.65 12/31/20236,030,000 shares $17.13 million +8.5%8.1%13.2 $2.84 12/15/20235,560,000 shares $17.18 million -5.3%7.4%12.4 $3.09 11/30/20235,870,000 shares $15.56 million -3.6%7.8%10.9 $2.65 11/15/20236,090,000 shares $15.23 million +10.7%8.1%10.4 $2.50 10/31/20235,500,000 shares $11.66 million +7.8%7.4%7.7 $2.12 10/15/20235,100,000 shares $13.16 million -4.3%6.8%7.7 $2.58 9/30/20235,330,000 shares $15.62 million +1.5%7.1%8.3 $2.93 9/15/20235,250,000 shares $16.98 million +38.2%7.0%7.8 $3.24Washington Is Broke—and Eyeing Your Savings Next (Ad)Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.Get your free guide now by clicking here >> 8/31/20233,800,000 shares $14.55 million +19.1%5.7%5.5 $3.83 8/15/20233,190,000 shares $14.29 million +6.3%4.9%5.1 $4.48 7/31/20233,000,000 shares $9.84 million No Change4.7%6.3 $3.28 7/15/20233,000,000 shares $9.09 million +2.4%4.7%6.6 $3.03 6/30/20232,930,000 shares $8.38 million -1.7%4.5%6.7 $2.86 6/15/20232,980,000 shares $9.98 million -31.0%5.4%7.8 $3.35 5/31/20234,320,000 shares $14.82 million -21.7%7.6%15.7 $3.43 5/15/20235,520,000 shares $22.00 million +5.8%10.2%21 $3.99 4/30/20235,220,000 shares $16.91 million +0.2%9.7%21.9 $3.24 4/15/20235,210,000 shares $16.93 million -1.0%9.6%23.2 $3.25 3/31/20235,260,000 shares $16.25 million +3.3%9.7%22.6 $3.09 3/15/20235,090,000 shares $14.51 million +2.2%9.4%19 $2.85 2/28/20234,980,000 shares $15.24 million +3.5%9.8%14.7 $3.06 2/15/20234,810,000 shares $15.34 million +7.1%9.4%14.5 $3.19 1/31/20234,490,000 shares $11.81 million +3.0%8.8%13 $2.63 1/15/20234,360,000 shares $10.90 million -4.2%8.6%11.8 $2.50 12/30/20224,550,000 shares $9.60 million +1.6%8.9%11.7 $2.11 12/15/20224,480,000 shares $11.65 million +1.8%8.6%11.4 $2.60 11/30/20224,400,000 shares $13.73 million -4.4%8.5%12.7 $3.12 11/15/20224,600,000 shares $13.66 million -19.3%8.9%12.6 $2.97 10/31/20225,700,000 shares $19.61 million -13.6%11.0%13.8 $3.44 10/15/20226,600,000 shares $20.79 million -17.7%12.7%16.5 $3.15 9/30/20228,020,000 shares $26.15 million +2.0%15.5%19.8 $3.26 9/15/20227,860,000 shares $32.15 million -6.5%15.2%18.1 $4.09 8/31/20228,410,000 shares $30.70 million -5.9%16.7%20.1 $3.65 8/15/20228,940,000 shares $42.73 million +2.6%17.7%19.1 $4.78 7/31/20228,710,000 shares $30.31 million +5.5%17.3%19.7 $3.48 7/15/20228,260,000 shares $28.91 million +10.0%16.4%18.2 $3.50 6/30/20227,510,000 shares $24.11 million +1.6%14.9%16.4 $3.21 6/15/20227,390,000 shares $27.93 million -2.1%14.7%16.3 $3.78 5/31/20227,550,000 shares $41.00 million +21.2%15.0%18.2 $5.43 5/15/20226,230,000 shares $33.46 million +5.8%12.3%16.8 $5.37 4/30/20225,890,000 shares $41.70 million +3.9%11.7%17.4 $7.08 4/15/20225,670,000 shares $41.79 million +15.2%11.2%15.8 $7.37 3/31/20224,920,000 shares $34.74 million +11.6%9.8%12.1 $7.06 3/15/20224,410,000 shares $25.00 million +10.3%8.7%9.9 $5.67 2/28/20224,000,000 shares $24.12 million +0.5%7.9%7.6 $6.03 2/15/20223,980,000 shares $23.04 million +14.7%7.9%7.3 $5.79 1/31/20223,470,000 shares $18.67 million +17.2%7.1%6.1 $5.38 1/15/20222,960,000 shares $17.26 million +21.3%N/A0 $5.83 12/31/20212,440,000 shares $17.69 million No Change5.0%4.1 $7.25 HUMA Short Interest - Frequently Asked Questions What is Humacyte's current short interest? Short interest is the volume of Humacyte shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 25,150,000 shares of HUMA short. 20.00% of Humacyte's shares are currently sold short. Learn More on Humacyte's current short interest. What is a good short interest ratio for Humacyte? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUMA shares currently have a short interest ratio of 7.0. Learn More on Humacyte's short interest ratio. Which institutional investors are shorting Humacyte? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Humacyte: Sculptor Capital LP, Simplex Trading LLC, and National Bank of Canada FI. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Humacyte? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.00% of Humacyte's floating shares are currently sold short. Is Humacyte's short interest increasing or decreasing? Humacyte saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 25,150,000 shares, a drop of 3.6% from the previous total of 26,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Humacyte's float size? Humacyte currently has issued a total of 155,119,000 shares. Some of Humacyte's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Humacyte currently has a public float of 125,750,000 shares. How does Humacyte's short interest compare to its competitors? 20.00% of Humacyte's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Humacyte: Vera Therapeutics, Inc. (12.17%), Dyne Therapeutics, Inc. (13.07%), ANI Pharmaceuticals, Inc. (9.23%), Ocular Therapeutix, Inc. (8.15%), Amphastar Pharmaceuticals, Inc. (9.22%), 89bio, Inc. (11.86%), Aurinia Pharmaceuticals Inc. (9.26%), Gyre Therapeutics, Inc. (13.99%), Mineralys Therapeutics, Inc. (16.91%), Wave Life Sciences Ltd. (8.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Humacyte stock? Short selling HUMA is an investing strategy that aims to generate trading profit from Humacyte as its price is falling. HUMA shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Humacyte? A short squeeze for Humacyte occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HUMA, which in turn drives the price of the stock up even further. How often is Humacyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUMA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Vera Therapeutics Short Interest Data Dyne Therapeutics Short Interest Data ANI Pharmaceuticals Short Interest Data Ocular Therapeutix Short Interest Data Amphastar Pharmaceuticals Short Interest Data 89bio Short Interest Data Aurinia Pharmaceuticals Short Interest Data Gyre Therapeutics Short Interest Data Mineralys Therapeutics Short Interest Data Wave Life Sciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HUMA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HUMA Stock Free HUMA Stock Alerts